secwatch.observer — SEC 8-K summary
======================================

Issuer:     INVO Fertility, Inc. (IVF)
CIK:        0001417926
Form:       8-K
Filed at:   2023-02-09T23:59:59+00:00
Accession:  0001493152-23-004074
Event type: debt
Sentiment:  neutral
Materiality: 0.65
Item codes: 1.01, 2.03, 3.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

INVO Bioscience enters $300K convertible debenture and up to $10M equity purchase agreement
--------------------------------------------------------------------------------

- Issued $300K principal convertible debenture to Peak One at $270K purchase price, 8% interest, convertible at $0.52/share.
- Issued warrant to buy 150K shares at $0.75 and 50K commitment shares as inducement.
- Entered equity purchase agreement for up to $10M of common stock in tranches at 97% of market price.
- Proceeds used for working capital and general corporate purposes.
- Registration rights agreement requires filing within 90 days for resale of convertible and warrant shares.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1417926/000149315223004074/0001493152-23-004074-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1417926/000149315223004074/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-23-004074

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer